Key result
Monocrotaline-induced pulmonary hypertension in mice decreased diaphragm maximal shortening velocity by 40% and peak power by 63% compared to control, without causing anorexia.
Why the study?
Does monocrotaline-induced pulmonary hypertension cause diaphragm atrophy and contractile dysfunction in mice?
Does monocrotaline-induced pulmonary hypertension cause diaphragm atrophy and contractile dysfunction in mice?
The murine model of pulmonary hypertension induced by monocrotaline mimics the loss of body weight and diaphragm muscle weakness seen in patients, validating its use for studying cachexia and respiratory muscle dysfunction in PH.
Answers are grounded in this paper and cite their sources.
Supports monocrotaline mouse model for PH cachexia research; leaves open translation to human diaphragm dysfunction.
Pulmonary hypertension (PH) causes loss of body weight and inspiratory (diaphragm) muscle dysfunction. A model of PH induced by drug (monocrotaline, MCT) has been extensively used in mice to examine the etiology of PH. However, it is unclear if PH induced by MCT in mice reproduces the loss of body weight and diaphragm muscle dysfunction seen in patients. This is a pre-requisite for widespread use of mice to examine mechanisms of cachexia and diaphragm abnormalities in PH. Thus, we measured body and soleus muscle weight, food intake, and diaphragm contractile properties in mice after 6-8 weeks of saline (control) or MCT (600 mg/kg) injections. Body weight progressively decreased in PH mice, while food intake was similar in both groups. PH decreased (P<0.05) diaphragm maximal isometric specific force, maximal shortening velocity, and peak power. Protein carbonyls in whole-diaphragm lysates and the abundance of select myofibrillar proteins were unchanged by PH. Our findings show diaphragm isometric and isotonic contractile abnormalities in a murine model of PH induced by MCT. Overall, the murine model of PH elicited by MCT mimics loss of body weight and diaphragm muscle weakness reported in PH patients.
No takes yet. Share an insight, caveat, or question.
Ahn et al. (2013) studied Pulmonary Hypertension (murine model). Monocrotaline (MCT) vs. Saline was evaluated on Diaphragm peak power (63% reduction, p=<0.05). Monocrotaline-induced pulmonary hypertension in mice decreased diaphragm maximal shortening velocity by 40% and peak power by 63% compared to control, without causing anorexia.
Synapse has enriched 10 related papers. Consider them for comparative context: